Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1 Oct. 2018 - 10 July 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- THE DEPARTMENT OF HEALTH OF THE GOVERNMENT OF THE UNITED KINGDOM, MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY
Test material
- Reference substance name:
- Vapour grown graphitic carbon fibre
- Molecular formula:
- C
- IUPAC Name:
- Vapour grown graphitic carbon fibre
Constituent 1
Test animals / tissue source
- Species:
- chicken
- Strain:
- other: Ross 308 Broiler
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Baileys Turkeys Ltd., Cheshire, UK
- Number of animals: multiple, not further specified
- Characteristics of donor animals: approx. 56 days old, approx. 3 kg
- Storage, temperature and transport conditions of ocular tissue: Heads were removed immediately after the chickens were killed, heads were stored individually in a transport box, transport box was lined with paper towel moistened with isotonic saline, heads were transported at ambient temperature
- Time interval prior to initiating testing: eyes were used on day of slaughter
- Indication of any existing defects or lesions in ocular tissue samples: no, eyes were examined for damages and corneal opacity, only acceptable eyes were used for test
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied (test item and positive control): 0.03 g
- Volume applied (negative control): 0.03 mL - Duration of treatment / exposure:
- 10 s
- Number of animals or in vitro replicates:
- Test item and positive control: triplicates
Negative control: duplicates - Details on study design:
- SELECTION AND PREPARATION OF ISOLATED EYES
Eyelids were carefully excised. The integrity of the cornea was measured with 2% (w/v) sodium fluorescein followed by rinsing with isotonic saline after a few seconds. The treated eyes were examined with a Haag-Streit BQ 900 (Switzerland) microscope. An acceptable eye had fluorescein retention and corneal opacity scores of <= 0.5. Acceptable eyes were dissected from the skull and pulled from the orbit by holding the nictitating membrane firmly with surgical forceps. The tissue behind the eye was carefully removed with bent, blunt-tipped scissors. A portion of the optic nerve remained on the removed eye. Other connective tissue was removed from the eye on an absorbent tray liner.
Enucleated eyes were transferred to an appropriate clamp keeping the cornea vertical. They were then transferred to chambers within the superfusion apparatus ensuring the corneas received sufficient isotonic saline from the saline drip. Once all eyes were placed in the superfusion apparatus, they were examined again with the Haag-Streit BQ 900 to ensure the eyes had not been damaged by the dissection procedure. Corneal thickness measurements are taken with a depth measuring device no. 1 on the Haag-Streit BQ 900 slit-lamp microscope at the center of each cornea. Eyes were replaced when: (i) the fluorescein score was > 0.5; (ii) the corneal opacity score was > 0.5; or (iii) there was any additional signs of damage, (iv) the corneal thickness measurements for individual eyes deviated more than 10% from the mean value for all eyes.
EQUILIBRATION AND BASELINE RECORDINGS
After the approval process, the eyes were incubated for approx. 45 min in an upright position at 30.5 - 33.5 °C for equilibrium purposes, time zero measurements for corneal thickness and opacity were taken to serve as baseline, baseline for the fluorescein measurements were taken at dissection.
OBSERVATION PERIOD
Treated corneas were evaluated prior to treatment, 30, 75, 120, 180 and 240 minutes after removal of test item / positive control.
REMOVAL OF TEST SUBSTANCE
- Volume and washing procedure after exposure period: The test item was rinsed off from the corneas with 20 mL isotonic saline .
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Corneal opacity was calculated with the most densely opacified areas for scoring. The mean value for all test eyes was calculated for all time points. The highest mean score, as observed at any time point was given an overall category for each test item.
- Damage to epithelium based on fluorescein retention: The mean fluorescein retention scores for all test eyes are calculated at the 30 min time interval only.
- Swelling: Percentage corneal swelling was assessed from corneal thickness measurements. Corneal thickness measurements are taken with a depth measuring device no. 1 on the Haag-Streit BQ 900 slit-lamp microscope at the center of each cornea. The calculation is expressed in the following formula: ((corneal thickness at time (t) - corneal thickness at time = 0)/ corneal thickness at time 0) x 100. The mean percentage of corneal swelling for all test eyes was calculated for all the time points. The overall category score was determined from the highest mean score for epithelial swelling as observed at any time point.
- Macroscopic morphological damage to the surface: pitting, sloughing or roughening of the epithelium
SCORING SYSTEM:
- Mean corneal swelling (%)
- Mean maximum opacity score
- Mean fluorescein retention score at 30 minutes post-treatment
DECISION CRITERIA:
The evaluation and decision criteria as indicated in the TG were used.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- Phase 1
- Value:
- 1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- Phase 1
- Value:
- 0.5
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- Phase 1
- Value:
- 13.4
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: 240 min
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- Phase 2
- Value:
- 0.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- Phase 2
- Value:
- 0.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- Phase 2
- Value:
- -0.5
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: 240 min
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: Phase 1: No morphological effects were noted in 2/3 (Phase 1) and 0/3 (Phase 2) test item-treated eyes and all negative and positive control-treated eyes (Phase 1 and 2). Adherence of the test item to the cornea was noted in 3/3 treated eyes during the observation period (Phase 1 and 2) and persisted in 1/3 (Phase 1) and 3/3 (Phase 2) treated eyes up to the 240 minute observation.
DEMONSTRATION OF TECHNICAL PROFICIENCY:
The Proficiency testing as recommended in OECD TG 438 to show suitability of substances for the ICE test in determining non GHS Category and Category 1 substances was performed at the test facility and is reported.
Any other information on results incl. tables
Table 1: Summary of Results
Phase 1 |
|||||||
Mean Corneal Opacity (ICE class) |
Mean Fluorescein Retention (ICE class) |
Mean Corneal Thickness compared to time zero % (ICE class) |
Combination of the 3 Endpoints |
||||
30 min |
75 min |
120 min |
180 min |
240 min |
|||
1.0 (II) |
0.5 (I) |
1.03 (I) |
10.31 (II) |
8.25 (II) |
8.25 (II) |
13.40 (II) |
|
(II) |
1 x I, 2 x II |
||||||
Classification: |
No Category |
||||||
Phase 2 |
|||||||
Mean Corneal Opacity (ICE class) |
Mean Fluorescein Retention (ICE class) |
Mean Corneal Thickness compared to time zero % (ICE class) |
Combination of the 3 Endpoints |
||||
30 min |
75 min |
120 min |
180 min |
240 min |
|||
0.8 (II) |
0.3 (I) |
-3.98 (I) |
-1.00 (I) |
-0.50 (I) |
-2.49 (I) |
-0.50 (I) |
|
(I) |
2 x I, 1 x II |
||||||
Classification: |
No Category |
mins: Minutes following treatment
Table 2: Individual Scores and Mean Scores for Corneal Effects – Test Item (Phase 1)
End Point |
Eye Number |
Time (after decontamination) [minutes] |
|||||||||
0 |
30 |
75 |
120 |
180 |
240 |
||||||
Corneal Opacity |
3A |
0 |
0.5 |
0.5 |
1 |
1 |
1 |
||||
6A |
0 |
0.5 |
1 |
1 |
1 |
1 |
|||||
8A |
0 |
0.5 |
0.5 |
0.5 |
0.5 |
1 |
|||||
Mean |
0.0 |
0.5 |
0.7 |
0.8 |
0.8 |
1.0 |
|||||
ICE Class |
II |
||||||||||
Fluorescein Retention |
3A |
|
0.5 |
|
|
|
|
||||
6A |
|
0.5 |
|
|
|
|
|||||
8A |
|
0.5 |
|
|
|
|
|||||
Mean |
|
0.5 |
|
|
|
|
|||||
ICE Class |
I |
||||||||||
Corneal Thickness |
3A |
0.63 |
0.62 |
0.72 |
0.70 |
0.68 |
0.74 |
||||
6A |
0.65 |
0.70 |
0.70 |
0.68 |
0.70 |
0.74 |
|||||
8A |
0.66 |
0.64 |
0.72 |
0.72 |
0.72 |
0.72 |
|||||
Mean |
0.65 |
0.65 |
0.71 |
0.70 |
0.70 |
0.73 |
|||||
Mean Corneal Swelling (%) |
|
1.03 |
10.31 |
8.25 |
8.25 |
13.40 |
|||||
ICE Class |
II |
||||||||||
Epithelium Condition |
3A |
|
TA |
TA |
TA |
TA |
N |
||||
6A |
|
TA |
TA |
TA |
TA |
TA |
|||||
8A |
|
TA |
N |
N |
N |
N |
|||||
ICE Classes Combined: |
1x I, 2 x II |
||||||||||
Classification: |
No Category |
||||||||||
TA: Test Item Adherence; N: Normal
Table 3: Individual Scores and Mean Scores for Corneal Effects – Test Item (Phase 2)
End Point |
Eye Number |
Time (after decontamination) [minutes] |
||||||
0 |
30 |
75 |
120 |
180 |
240 |
|||
Corneal Opacity |
3A |
0.5 |
0.5 |
0.5 |
0.5 |
1 |
1 |
|
6A |
0.5 |
0.5 |
0.5 |
1 |
1 |
1 |
||
8A |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
||
Mean |
0.5 |
0.5 |
0.5 |
0.7 |
0.8 |
0.8 |
||
ICE Class |
II |
|||||||
Fluorescein Retention |
3A |
|
0.5 |
|
|
|
|
|
6A |
|
0.5 |
|
|
|
|
||
8A |
|
0 |
|
|
|
|
||
Mean |
|
0.3 |
|
|
|
|
||
ICE Class |
I |
|||||||
Corneal Thickness |
3A |
0.68 |
0.65 |
0.72 |
0.75 |
0.70 |
0.68 |
|
6A |
0.67 |
0.63 |
0.650 |
0.64 |
0.66 |
0.65 |
||
8A |
0.66 |
0.65 |
0.62 |
0.61 |
0.60 |
0.67 |
||
Mean |
0.67 |
0.64 |
0.66 |
0.67 |
0.65 |
0.67 |
||
Mean Corneal Swelling (%) |
|
-3.98 |
-1.00 |
-0.50 |
-2.49 |
-0.50 |
||
ICE Class |
I |
|||||||
Epithelium Condition |
3A |
|
TA |
TA |
TA |
TA |
TA |
|
6A |
|
TA |
TA |
TA |
TA |
TA |
||
8A |
|
TA |
TA |
TA |
TA |
TA |
||
ICE Classes Combined: |
2x I, 1 x II |
|||||||
Classification: |
No Category |
|||||||
TA: Test Item Adherence
Table 4: Individual Scores and Mean Scores for Corneal Effects – Positive Control (Phase 1)
End Point |
Eye Number |
Time (after decontamination) [minutes] |
|||||
0 |
30 |
75 |
120 |
180 |
240 |
||
Corneal Opacity |
2A |
0 |
4 |
4 |
4 |
4 |
4 |
5A |
0 |
4 |
4 |
4 |
4 |
4 |
|
7A |
0 |
4 |
4 |
4 |
4 |
4 |
|
Mean |
0.0 |
4.0 |
4.0 |
4.0 |
4.0 |
4.0 |
|
ICE Class |
IV |
||||||
Fluorescein Retention |
2A |
|
3 |
|
|
|
|
5A |
|
3 |
|
|
|
|
|
7A |
|
3 |
|
|
|
|
|
Mean |
|
3.0 |
|
|
|
|
|
ICE Class |
IV |
||||||
Corneal Thickness |
2A |
0.67 |
0.70 |
0.82 |
0.82 |
0.90 |
0.86 |
5A |
0.64 |
0.78 |
0.86 |
0.86 |
0.90 |
0.88 |
|
7A |
0.63 |
0.76 |
0.83 |
0.88 |
0.86 |
0.90 |
|
Mean |
0.65 |
0.75 |
0.84 |
0.85 |
0.89 |
0.88 |
|
Mean Corneal Swelling (%) |
|
15.46 |
29.38 |
31.96 |
37.11 |
36.08 |
|
ICE Class |
IV |
||||||
Epithelium Condition |
2A |
|
N |
N |
N |
N |
N |
5A |
|
N |
N |
N |
N |
N |
|
7A |
|
N |
N |
N |
N |
N |
|
ICE Classes Combined: |
3 x IV |
||||||
Classification: |
Category 1 |
N: Normal
Table 5: Individual Scores and Mean Scores for Corneal Effects – Positive Control (Phase 2)
End Point |
Eye Number |
Time (after decontamination) [minutes] |
|||||
0 |
30 |
75 |
120 |
180 |
240 |
||
Corneal Opacity |
2A |
0 |
4 |
4 |
4 |
4 |
4 |
5A |
0 |
4 |
4 |
4 |
4 |
4 |
|
7A |
0.5 |
4 |
4 |
4 |
4 |
4 |
|
Mean |
0.2 |
4.0 |
4.0 |
4.0 |
4.0 |
4.0 |
|
ICE Class |
IV |
||||||
Fluorescein Retention |
2A |
|
3 |
|
|
|
|
5A |
|
3 |
|
|
|
|
|
7A |
|
3 |
|
|
|
|
|
Mean |
|
3.0 |
|
|
|
|
|
ICE Class |
IV |
||||||
Corneal Thickness |
2A |
0.65 |
0.83 |
0.91 |
0.95 |
0.91 |
0.94 |
5A |
0.61 |
0.78 |
0.77 |
0.84 |
0.82 |
0.87 |
|
7A |
0.68 |
0.79 |
0.83 |
0.91 |
0.94 |
0.96 |
|
Mean |
0.65 |
0.80 |
0.84 |
0.90 |
0.89 |
0.92 |
|
Mean Corneal Swelling (%) |
|
23.71 |
29.38 |
39.18 |
37.63 |
42.78 |
|
ICE Class |
IV |
||||||
Epithelium Condition |
2A |
|
N |
N |
N |
N |
N |
5A |
|
N |
N |
N |
N |
N |
|
7A |
|
N |
N |
N |
N |
N |
|
ICE Classes Combined: |
3 x IV |
||||||
Classification: |
Category 1 |
N: Normal
Table 6: Individual Scores and Mean Scores for Corneal Effects – Negative Control (Phase 1)
End Point |
Eye Number |
Time (after decontamination) [minutes] |
|||||
0 |
30 |
75 |
120 |
180 |
240 |
||
Corneal Opacity |
1A |
0 |
0 |
0 |
0 |
0 |
0 |
4A |
0 |
0 |
0 |
0 |
0 |
0 |
|
Mean |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
ICE Class |
I |
||||||
Fluorescein Retention |
1A |
|
0 |
|
|
|
|
4A |
|
0 |
|
|
|
|
|
Mean |
|
0.0 |
|
|
|
|
|
ICE Class |
I |
||||||
Corneal Thickness |
1A |
0.64 |
0.64 |
0.66 |
0.64 |
0.66 |
0.64 |
4A |
0.66 |
0.64 |
0.67 |
0.66 |
0.68 |
0.66 |
|
Mean |
0.65 |
0.64 |
0.67 |
0.65 |
0.67 |
0.65 |
|
Mean Corneal Swelling (%) |
|
-1.54 |
2.31 |
0.00 |
3.08 |
0.00 |
|
ICE Class |
I |
||||||
Epithelium Condition |
1A |
|
N |
N |
N |
N |
N |
4A |
|
N |
N |
N |
N |
N |
|
ICE Classes Combined: |
3 x I |
||||||
Classification: |
No Category |
N: Normal
Table 7: Individual Scores and Mean Scores for Corneal Effects – Negative Control (Phase 2)
End Point |
Eye Number |
Time (after decontamination) [minutes] |
|||||
0 |
30 |
75 |
120 |
180 |
240 |
||
Corneal Opacity |
1A |
0 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
4A |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
|
Mean |
0.3 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
|
ICE Class |
I |
||||||
Fluorescein Retention |
1A |
|
0.5 |
|
|
|
|
4A |
|
0.5 |
|
|
|
|
|
Mean |
|
0.5 |
|
|
|
|
|
ICE Class |
I |
||||||
Corneal Thickness |
1A |
0.61 |
0.62 |
0.62 |
0.59 |
0.59 |
0.58 |
4A |
0.64 |
0.61 |
0.62 |
0.61 |
0.61 |
0.65 |
|
Mean |
0.63 |
0.62 |
0.62 |
0.60 |
0.60 |
0.62 |
|
Mean Corneal Swelling (%) |
|
-1.60 |
-0.80 |
-4.00 |
-4.00 |
-1.60 |
|
ICE Class |
I |
||||||
Epithelium Condition |
1A |
|
N |
N |
N |
N |
N |
4A |
|
N |
N |
N |
N |
N |
|
ICE Classes Combined: |
3 x I |
||||||
Classification: |
No Category |
N: Normal
Table 8: Historical control data, Negative Controls
Study Number |
Negative control |
Date |
Maximum Mean CO |
Maximum Mean % CT |
Maximum Mean FR |
ME |
CR76PS |
saline |
30/01/2017 |
0.3 |
5.19 |
0 |
None |
VQ32JY |
saline |
30/01/2017 |
0.5 |
2.11 |
0 |
None |
HK86QX |
saline |
03/10/2016 |
0.3 |
2.16 |
0.3 |
None |
PJ73HL |
saline |
05/12/2016 |
0.3 |
2.86 |
0 |
None |
KX84DP |
saline |
28/11/2016 |
0.3 |
2.9 |
0 |
None |
KK41FP |
saline |
22/08/2016 |
0.5 |
3.57 |
0 |
None |
41502580 |
saline |
11/01/2016 |
0.5 |
7.04 |
0.5 |
None |
41502299 |
saline |
09/11/2015 |
0.5 |
‐0.7 |
0 |
None |
41502380 |
saline |
12/10/2015 |
0.5 |
1.42 |
0.3 |
None |
ME: Morphological effects; FR: Fluorescein Retention; CT: Corneal Thickness; CO: Corneal Opacity
Table 9: Historical control data, Positive Controls
Study Number |
Positive control |
Date |
Maximum Mean CO |
Maximum Mean % CT |
Maximum Mean FR |
ME |
CR76PS |
5% Benzalkonium chloride |
30/01/2017 |
4 |
54.23 |
3 |
S (two eyes) |
VQ32JY |
5% Benzalkonium chloride |
30/01/2017 |
4 |
53.77 |
3 |
S (three eyes) |
HK86QX |
Imidazole |
03/10/2016 |
4 |
46.92 |
3 |
S (one eye) |
PJ73HL |
5% Benzalkonium chloride |
05/12/2016 |
4 |
44.5 |
3 |
S (two eyes) |
KX84DP |
5% Benzalkonium chloride |
28/11/2016 |
2.7 |
35.71 |
2.7 |
S (one eye) |
KK41FP |
5% Benzalkonium chloride |
22/08/2016 |
3.7 |
38.54 |
3 |
S (three eyes) |
41502580 |
5% Benzalkonium chloride |
11/01/2016 |
4 |
45.41 |
3 |
S (three eyes) |
41502299 |
5% Benzalkonium chloride |
09/11/2015 |
4 |
47.89 |
3 |
S (three eyes) |
41502380 |
5% Benzalkonium chloride |
12/10/2015 |
4 |
34.12 |
3 |
S (one eye) |
ME: Morphological effects; FR: Fluorescein Retention; CT: Corneal Thickness; S: Sloughing (loosening); CO: Corneal Opacity
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008.
- Conclusions:
- In two independent experiments, the test material was assessed to have no potential to cause eye irritation or serious eye damage in the Isolated Chicken Eye test. No classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.